Back to search results

Observational Study of Patient Samples and Data

This is an observational study collecting existing patient samples and data related to pregnancy, cancer, and infectious diseases. It's not testing a new treatment, but rather using "remnant samples" (leftover samples from routine diagnostic tests) and corresponding health information for future research and development. The study aims to gather these samples and data from patients who are of scientific interest to the sponsor or their doctor. Success for this study means collecting these de-identified samples and data for research purposes. The study plans to include up to 2000 participants. The current recruitment status is unclear.

Study design
This is an observational study, meaning it collects information without giving any new treatments. It plans to include up to 2000 participants.
What's involved
If you are of scientific interest and provide written informed consent, your clinical sample and/or supporting clinical data will be collected. Samples and data may be collected for up to 12 months after enrollment.
Compensation
Not stated in the trial record.
Follow-up
Samples and data may be collected for up to 12 months after enrollment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04364503

Compliant Analysis of Patient Samples and Data

Enrolling by Invitation
Not specifiedAll AgesObservational
Sequenom, Inc.
~2,000 participants
Updated 2026-07-21 on ClinicalTrials.gov
What's tested:Multiple interventions depending on diagnostic test being run.

At a glance

Recruiting sites
0 of 9 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Remnant samples and data for research and development
Measured over Retrospective and Prospective collection. Samples and data may be collected for up 12 months after enrollment.
+1 more outcome measured

Conditions

Pregnancy Related
Cancer
Infectious Disease

Explore related trials

Infectious DisorderMalignant NeoplasmPregnancy Related

Where it's being run

9 sites across 5 states
California3
North Carolina3
Colorado1
Illinois1
New York1

Study leadership

  • Graham P McLennan · PRINCIPAL_INVESTIGATOR · Sequenom, Inc.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Arm 1
All samples and data are de-identified and HIPAA compliant
Arm 2
Subject is of scientific interest to the Sponsor or treating physician
Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected.

Exclusion

Arm 1
Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development
Arm 2
Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent

What this trial measures

  • Remnant samples and data for research and developmentRetrospective and Prospective collection. Samples and data may be collected for up 12 months after enrollment.

    Remnant samples and data for research and development

  • Sample and data collection from subjects of scientific interestProspective collection. Samples and data may be collected for up to 12 months after enrollment

    Collect additional clinical data and samples if needed from subjects tested by LabCorp or an affiliate.